E. Ebbel

Identification of Phenylbutyrate-Generated Metabolites in Huntington Disease Patients using Parallel LC/EC-array/MS and Off-line Tandem MS

N. Leymarie, S. Hersch, W. Matson, 2013 .

Identification of phenylbutyrate-generated metabolites in Huntington disease patients using parallel liquid chromatography/electrochemical array/mass spectrometry and off-line tandem mass spectrometry.

N. Leymarie, S. Hersch, W. Matson, 2010, Analytical biochemistry.

Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2′dG

M. F. Beal, H. Zhang, L. Zhang, 2006, Neurology.